Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
Frontiers in Psychiatry
|
December 5, 2022
A survey of drug liking and cravings in patients using sublingual or intranasal ketamine for treatment resistant depression: A preliminary evaluation of real world addictive potential
Brittany Chubbs, Jay Wang, Shaina Archer, et al.
Journal of Child and Adolescent Psychopharmacology
|
October 29, 2021
Effect of a Multilayer, Extended-Release Methylphenidate Formulation (PRC-063) on Sleep in Adolescents with Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Fixed-Dose, Placebo-Controlled Trial Followed by a 6-Month Open-Label Follow-Up
Margaret Danielle Weiss, Craig Surman, Atul Khullar, et al.
Sleep Medicine
|
August 23, 2025
Effect of lemborexant on sleep parameters and architecture in adult and elderly participants with mild-to-severe obstructive sleep apnea
Atul Khullar, Mark I Boulos, Michael S B Mak, et al.
Therapeutic Advances in Psychopharmacology
|
March 5, 2024
Patient-reported outcomes on sleep quality and circadian rhythm during treatment with intravenous ketamine for treatment-resistant depression
Raymond Yan, Tyler Marshall, Atul Khullar, et al.
CNS Drugs
|
February 15, 2022
Non-parenteral Ketamine for Depression: A Practical Discussion on Addiction Potential and Recommendations for Judicious Prescribing
Jennifer Swainson, Larry J Klassen, Stefan Brennan, et al.
Therapeutic Advances in Psychopharmacology
|
May 23, 2020
Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers
Dmitriy Matveychuk, Rejish K Thomas, Jennifer Swainson, et al.
Psychiatry Research
|
May 16, 2026
Ketamine and esketamine for the prevention of postpartum depression: A systematic review and network meta-analysis, with an integrated evidence synthesis
Isis Lunsky, Gilmar Gutierrez, Xena Wang, et al.
Sleep Medicine: X
|
April 6, 2026
Effects of lemborexant on sleep quality and its association with morning alertness: Post hoc analysis of two phase 3 trials
Masahiro Suzuki, Takuya Yoshiike, Atul Khullar, et al.
The Primary Care Companion for CNS Disorders
|
November 12, 2016
Functional Recovery in Major Depressive Disorder: Focus on Early Optimized Treatment
Jeffrey Habert, Martin A Katzman, Oloruntoba J Oluboka, et al.
Sleep Medicine
|
October 31, 2024
Delphi consensus recommendations for the management of chronic insomnia in Canada
Charles M Morin, Atul Khullar, Rebecca Robillard, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
Frontiers in Psychiatry
|
December 5, 2022
A survey of drug liking and cravings in patients using sublingual or intranasal ketamine for treatment resistant depression: A preliminary evaluation of real world addictive potential
Brittany Chubbs, Jay Wang, Shaina Archer, et al.
Journal of Child and Adolescent Psychopharmacology
|
October 29, 2021
Effect of a Multilayer, Extended-Release Methylphenidate Formulation (PRC-063) on Sleep in Adolescents with Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Fixed-Dose, Placebo-Controlled Trial Followed by a 6-Month Open-Label Follow-Up
Margaret Danielle Weiss, Craig Surman, Atul Khullar, et al.
Sleep Medicine
|
August 23, 2025
Effect of lemborexant on sleep parameters and architecture in adult and elderly participants with mild-to-severe obstructive sleep apnea
Atul Khullar, Mark I Boulos, Michael S B Mak, et al.
Therapeutic Advances in Psychopharmacology
|
March 5, 2024
Patient-reported outcomes on sleep quality and circadian rhythm during treatment with intravenous ketamine for treatment-resistant depression
Raymond Yan, Tyler Marshall, Atul Khullar, et al.
CNS Drugs
|
February 15, 2022
Non-parenteral Ketamine for Depression: A Practical Discussion on Addiction Potential and Recommendations for Judicious Prescribing
Jennifer Swainson, Larry J Klassen, Stefan Brennan, et al.
Therapeutic Advances in Psychopharmacology
|
May 23, 2020
Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers
Dmitriy Matveychuk, Rejish K Thomas, Jennifer Swainson, et al.
Psychiatry Research
|
May 16, 2026
Ketamine and esketamine for the prevention of postpartum depression: A systematic review and network meta-analysis, with an integrated evidence synthesis
Isis Lunsky, Gilmar Gutierrez, Xena Wang, et al.
Sleep Medicine: X
|
April 6, 2026
Effects of lemborexant on sleep quality and its association with morning alertness: Post hoc analysis of two phase 3 trials
Masahiro Suzuki, Takuya Yoshiike, Atul Khullar, et al.
The Primary Care Companion for CNS Disorders
|
November 12, 2016
Functional Recovery in Major Depressive Disorder: Focus on Early Optimized Treatment
Jeffrey Habert, Martin A Katzman, Oloruntoba J Oluboka, et al.
Sleep Medicine
|
October 31, 2024
Delphi consensus recommendations for the management of chronic insomnia in Canada
Charles M Morin, Atul Khullar, Rebecca Robillard, et al.
Page
of 3